Company: HCWB
Filing Date: 2025-05-15
Form Type: 8-K
Source: 0000950170-25-072700
Chunk: 4

Company: HCW Biologics Inc.
Filing Date: 2025-05-15
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                      
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          4.1      Form of Common Stock Purchase Warrant                                                            
          4.2      Form of Pre-Funded Common Stock Purchase Warrant                                                 
          4.3      Form of amended and restated Common Stock Purchase Warrant                                       
         10.1      Placement Agency Agreement, dated May 13, 2025, between the Company and Maxim Group LLC          
         10.2      Securities Purchase Agreement, dated May 13, 2025, between the Company and Purchaser             
         10.3      Amendment to Existing Warrants Agreement, dated May 13, 2025, between the Company and Purchaser  
         99.1      Press release, dated May 13, 2025, announcing pricing of the Offering                            

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        HCW BIOLOGICS INC.                   
  Date:      May 15, 2025      By:      /s/ Hing C. Wong                     
                                        Hing C. Wong